Moreover, we observed that CDH17 x GUCY2C BsADC treatment resulted in increased MDA and 4-HNE levels in tumor tissue compared to CDH17-ADC or GUCY2C-ADC treatment (Fig. 5B, C). Here, CDH17 is linked to neoplasm.